Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.59
+0.47 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
55
56
Next >
Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids
October 21, 2022
Physicians are reporting a sharp increase in cases of the respiratory syncytial virus (RSV), creating capacity issues in several children's hospitals in the U.S. before the typically busier winter...
Via
Benzinga
3 Alzheimer's Therapy Stocks to Invest in
October 21, 2022
Alzheimer's treatments could make a big winner of these stocks.
Via
The Motley Fool
AstraZeneca Announces Winners of Fourth Annual Cancer Community Awards
October 20, 2022
From
AstraZeneca
Via
Business Wire
Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny
October 20, 2022
Boston University created an artificial form of COVID-19 in a laboratory. Now, U.S. health officials have launched an inquiry into a controversial study. The Boston University research was designed to...
Via
Benzinga
This Growth Stock Rose Last Week. Is It Still a Buy?
October 18, 2022
Illumina is the dominant player in gene sequencing.
Via
The Motley Fool
Beat the Dow Jones With This Unstoppable Dividend Stock
October 19, 2022
This pharmaceutical stock combines strong financials with an above-average dividend.
Via
The Motley Fool
7 Stocks to Buy When There’s Blood in the Streets
October 18, 2022
For investors looking for high-quality stocks to buy when there is blood in the streets, there happen to be plenty of companies to pick.
Via
InvestorPlace
2 Top Healthcare Stocks to Buy for the Long Haul
October 18, 2022
These biotech companies have a long ramp of revenue growth ahead.
Via
The Motley Fool
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division.
Via
InvestorPlace
Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway
October 18, 2022
From
Ikena Oncology, Inc.
Via
GlobeNewswire
Is This Monster Stock on the Verge of a Home Run?
October 17, 2022
Ultomiris was just approved in the European Union to treat patients with generalized myasthenia gravis.
Via
The Motley Fool
2 Top Biotech Stocks to Buy Right Now
October 14, 2022
Healthcare is a reliable sector of the economy for those looking to create wealth over the long haul.
Via
The Motley Fool
3 Incredibly Cheap Blue Chip Stocks to Buy Right Now
October 13, 2022
It's time to buy the dip in these blue chip stocks.
Via
The Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $100
October 12, 2022
There's no need to break the bank to buy quality stocks.
Via
The Motley Fool
Is Seagen Stock a Buy Now?
October 12, 2022
It's growing faster than competitors, but headwinds might soon bog it down.
Via
The Motley Fool
Alexion aims to advance NMOSD treatment landscape with exceptional ULTOMIRIS® (ravulizumab-cwvz) efficacy data at ECTRIMS 2022
October 12, 2022
From
Alexion
Via
Business Wire
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...
Via
FinancialNewsMedia
Exposures
COVID-19
Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery
October 11, 2022
Via
Benzinga
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
October 11, 2022
Reuters US-China Chip War: KLA Relaxes Chip Supply To China
Via
Benzinga
AstraZeneca-Oxford University Partnered Nasal COVID-19 Vaccine Flunks Human Trial
October 11, 2022
AstraZeneca Plc (NASDAQ: AZN) and Oxford University scientists said that the initial testing of its nasal COVID-19 vaccine did not yield the desired protection.
Via
Benzinga
Have $2,000? 2 Market Crash-Ready Stocks to Buy
October 09, 2022
These two big pharma stocks have what it takes to bounce back.
Via
The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
October 08, 2022
If given enough time, these two stocks can do the heavy lifting in building wealth for you.
Via
The Motley Fool
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused
Via
MarketBeat
Topics
Earnings
Economy
Lawsuit
Exposures
Financial
Legal
Supply Chain
Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio
October 03, 2022
Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.
Via
Talk Markets
Will Chart Analysts Notice Bad Omen on AstraZeneca's Chart
October 03, 2022
If history is any guide, there may be trouble ahead for shares of AstraZeneca (NASDAQ:AZN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the...
Via
Benzinga
Why Is LogicBio (LOGC) Stock Up 600% Today?
October 03, 2022
LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.
Via
InvestorPlace
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
Vaccines that boost the body’s immune system against foreign proteins are different than those that are an inverse vaccine fighting an autoimmune disease.
Via
Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
October 03, 2022
LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share.
Via
Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
Via
Benzinga
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
October 03, 2022
From
Alexion
Via
Business Wire
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.